Garcia, E.; Osté, M.C.J.; Bennett, D.W.; Jeyarajah, E.J.; Shalaurova, I.; Gruppen, E.G.; Hazen, S.L.; Otvos, J.D.; Bakker, S.J.L.; Dullaart, R.P.F.;
et al. High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. J. Clin. Med. 2019, 8, 1813.
https://doi.org/10.3390/jcm8111813
AMA Style
Garcia E, Osté MCJ, Bennett DW, Jeyarajah EJ, Shalaurova I, Gruppen EG, Hazen SL, Otvos JD, Bakker SJL, Dullaart RPF,
et al. High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Journal of Clinical Medicine. 2019; 8(11):1813.
https://doi.org/10.3390/jcm8111813
Chicago/Turabian Style
Garcia, Erwin, Maryse C. J. Osté, Dennis W. Bennett, Elias J. Jeyarajah, Irina Shalaurova, Eke G. Gruppen, Stanley L. Hazen, James D. Otvos, Stephan J. L. Bakker, Robin P.F. Dullaart,
and et al. 2019. "High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study" Journal of Clinical Medicine 8, no. 11: 1813.
https://doi.org/10.3390/jcm8111813
APA Style
Garcia, E., Osté, M. C. J., Bennett, D. W., Jeyarajah, E. J., Shalaurova, I., Gruppen, E. G., Hazen, S. L., Otvos, J. D., Bakker, S. J. L., Dullaart, R. P. F., & Connelly, M. A.
(2019). High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Journal of Clinical Medicine, 8(11), 1813.
https://doi.org/10.3390/jcm8111813